سعر نيو-كلاف اكسترا سترنث 642.9مجم/5مل معلق 50 مل 2024

New-clav Extra Strength 642.9 mg/5 ml oral suspension 50 ml (Sigma Tec / Andalous Pharma): amoxicillin with clavulanic acid paediatric/ES-strength suspension.

• Lower respiratory tract infections, acute bacterial otitis media, sinusitis, skin and skin structure infections, and urinary tract infections caused by susceptible beta-lactamase-producing bacteria (US Augmentin labeling indications — summary).DailyMed (NLM)

• History of serious hypersensitivity reactions (e.g. anaphylaxis or Stevens-Johnson syndrome) to amoxicillin, clavulanate, or other beta-lactam antibacterials (penicillins or cephalosporins); history of cholestatic jaundice/hepatic dysfunction associated with amoxicillin-clavulanate (US Augmentin labeling).International label, equivalent formulation · DailyMed (NLM)

• Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy; Clostridium difficile-associated diarrhea (CDAD) has been reported with nearly all antibacterial agents including amoxicillin-clavulanate (US Augmentin labeling).International label, equivalent formulation · DailyMed (NLM)
• Hepatic dysfunction, including hepatitis and cholestatic jaundice, has been associated with amoxicillin-clavulanate; use caution in patients with evidence of hepatic dysfunction (US Augmentin labeling).International label, equivalent formulation · DailyMed (NLM)

• ProbenecidModerateProbenecid decreases the renal tubular secretion of amoxicillin; concurrent use may result in increased and prolonged blood levels of amoxicillin (US Augmentin labeling).DailyMed (NLM)

• Available data from published epidemiologic studies and postmarketing case reports concerning use of amoxicillin-clavulanate in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes; animal studies showed no evidence of fetal harm at doses relevant to human exposure (US Augmentin labeling — summary).International label, equivalent formulation · DailyMed (NLM)
• Amoxicillin is excreted in human milk; there are no data on the effects of amoxicillin-clavulanate on the breastfed child or milk production. Developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need (US Augmentin labeling).International label, equivalent formulation · DailyMed (NLM)

• Amoxicillin: Bactericidal beta-lactam that inhibits bacterial cell-wall biosynthesis during active multiplication; inactivated by beta-lactamases (US label, section 12.4).
• Clavulanic acid: Beta-lactam that inactivates some beta-lactamases, protecting amoxicillin from degradation.